Exosomes as perioperative therapeutics to limit organ injury.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36682935.
- Also identified by DOI 10.1016/j.bja.2022.12.014.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Perioperative organ injury is a frequent and major complication for the ∼240 million people undergoing surgery worldwide annually. Ischaemic preconditioning is a powerful technique that reduces organ injury in experimental models of heart, lung, gut, brain, and kidney ischaemia-reperfusion injury. However, ischaemic preconditioning has been a challenge to translate into clinical practice. We describe how utilising isolated pre-conditioned exosomes (secreted vesicles containing many cell-survival mediators), some of the translational hurdles of ischaemic preconditioning can be overcome. Delivery of exosomes in the perioperative period could become a promising new therapeutic strategy to prevent perioperative organ injury.
Medical subject headings
- Exosomes
- Reperfusion Injury
- Ischemic Preconditioning
- Ischemic Preconditioning, Myocardial